摘要
目的:观察红景天对肿瘤患者免疫功能的影响及调节作用。方法:用红景天连服20天,对比胸腺肽及空白对照观察78例肿瘤患者体液免疫与细胞免疫功能的指标变化。结果:空白对照组肿瘤患者细胞免疫均有下降,(P<0.001或P<0.05);而服用红景天组和胸腺肽组的肿瘤患者,治疗后能使患者的细胞免疫平稳,治疗前后无显著性差异(P>0.05)。三组肿瘤患者治疗前后的体液免疫均无明显变化。结论:红景天组和胸腺肽组治疗前后的疗效相当,对肿瘤患者的细胞免疫有上调的作用,且未发现毒副反应,使用安全,可以作为调节免疫的辅助化疗药应用于临床。
Objectice： To explore the effect and immunologic regulation of Rhodiola L. for tumor patients. Methods： Some patients were required to take Rhodiola for 20 days. Then, the index change of humoral immunity and cellular immunity were compared with those in patients who took Thymosin and those in blank control group. Results： Cellular immunity decreased in blank control group （P 〈 0.001 or P 〈 0.05） . In the groups that took Rhodiola L. and Thymosin, the cellular immunity became more steady after the treatment, without any remarkable difference （P 〉 0.05） . It could show more clear resuh ff enlarging the number of samples. As for humoral immunity, there was no notable change in each group after the treatment. Conclusion： Rhodiola L. and Thymosin have almost the same curative effect to increase cellular immunity of tumor patients without toxic or side effect. Rhodlola L. can be used clinically as a subsidiary medicine of chemotherapy to adjust the immunity.
出处
《四川中医》
北大核心
2008年第9期47-49,共3页
Journal of Sichuan of Traditional Chinese Medicine
